Company: PCRX
Filing Date: 2025-03-14
Form Type: DFAN14A
Source: 0000921895-25-000772
Chunk: 2

Company: Pacira BioSciences, Inc.
Filing Date: 2025-03-14
Form: DFAN14A
Chunk 2
---
.

DOMA’s aim is to accelerate buybacks
to enhance shareholder value, returning to shareholders the vast majority of the cash on the balance sheet and free cash flow, for as
long as it is accretive. DOMA believes the Board must avoid taking any substantial risk in capital allocation until certainty in the
IP battle is achieved. It is time to put Pacira’s shareholders first.

Director Nominees:

| · | Joseph Kromholz – Mr. Kromholz is a highly skilled attorney in all areas of intellectual               
 property law including patent, trademark, copyright and unfair competition law and related litigation. |

| · | Philip Pucciarelli – Mr. Pucciarelli is a seasoned financial professional who has spent more                                             
 than 25 years in Investment Banking with a focus on M&A, strategic capital raising and corporate finance advisory for public and private 
 Healthcare services companies.                                                                                                           |

| · | Eric de Armas – Mr. de Armas, CFO and CCO of DOMA Perpetual, has over two decades of experience                                  
 in the financial industry. He possesses a deep knowledge of corporate finance, risk management and strategic capital allocation. |

About DOMA Perpetual Capital Management LLC:DOMA Perpetual Capital Management LLC is an asset management firm based in Miami, Florida. DOMA Perpetual strives to achieve great
investment results by identifying attractive, uncorrelated companies with sustainable competitive advantages, while limiting exposure
to downside risks. It employs an opportunistic, fundamentals-based strategy that invests in companies across a variety of sectors and
market caps throughout the globe.

Contact:DOMA Perpetual Capital Management LLC
ir@domaperpetual.com

<div align='center'>CERTAIN INFORMATION CONCERNING THE PARTICIPANTS</div>

DOMA Perpetual Capital Management LLC, a Delaware
limited liability company (“DOMA”), together with the other participants named herein, have filed a preliminary proxy statement
and accompanying WHITE proxy card with the Securities and Exchange Commission (“SEC”) to be used to solicit votes for the
election of its slate of director nominees at the 2025 annual meeting of stockholders of Pacira BioSciences, Inc., a Delaware corporation
(the “Company”).

DOMA STRONGLY ADVISES ALL STOCKHOLDERS OF THE
COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
SUCH PROXY MATERIAL